News & Media

We invite you to follow our progress as we move forward in the completion and installation of our first high-efficiency,environmentally responsible urea manufacturing plants. Subscribe today to receive news, updates and investor alerts.

Press Releases

Plant Construction Updates

Sign Up for
Investor Alerts

press releases

BioNitrogen Holdings Corp. Appoints Graham Copley to Board of Directors

  • Bion User
  • September. 09, 2015

MIAMI, Sept. 9, 2015 /PRNewswire/ — BioNitrogen Holdings Corp. (OTC PINK: BION), a Clean Tech company that owns breakthrough, disruptive technology to produce urea fertilizer from biomass, today announced the appointment of Graham Copley to its board of directors, effective immediately.

BioNitrogen Holdings Corp. Logo

Graham Copley is a co-founder of Pentant LLC, a strategic advisory business based in Stamford, CT.  Graham is a trained chemical engineer and has spent roughly half of his career in the chemical industry and half in investment research and investment banking.

“Graham brings a wealth of knowledge and experience in the Chemical and Financial Industries to BioNitrogen and will play a key role as we achieve crucial milestones to enable the construction of our first plant in Florida, and subsequent plants thereafter,” said Carlos Contreras, chairman and chief executive officer of BioN. “His strategic approach and analytical insight in the chemicals space will be a tremendous asset to BioNitrogen. Pentant has been advising BioNitrogen since July and Graham’s acceptance of this role indicates the level of commitment and confidence that Graham and his team have in our process and our future. We are pressing ahead diligently with the accounting work and engineering work that is required to get us to a final investment approval for the first plant,” added Carlos.

Prior to founding Pentant, Graham Copley was Head of US Equities for Macquarie Securities Group, a Board director of Macquarie SecuritiesUSA for 3 years, and a member of the US management committee of Macquarie. Prior to Macquarie, Graham held the role of Global Head of Equity Research for HSBC. In addition to management roles in the equity business, he was a research analyst at Sanford C Bernstein & Co. LLC from 1996 to 2004, covering the chemical industry, where he was consistently ranked within the top three analysts in the sector.

“I am honored to have been selected to sit on BioNitrogen’s board,” said Graham. “What BioNitrogen is trying to do is not an easy undertaking, as there are very few examples of new technologies launching successfully in the broad Chemical sector over the last few decades. However, BioNitrogen has tried and tested technologies in most stages of the process and this makes things somewhat easier; but probably more important, the company has an offering that people want.  While I am impressed by the number of US opportunities that appear to exist, in addition to the initial project, these may be overwhelmed at some stage by opportunities outside the US, where Urea prices are often significantly higher.”  Graham adds: “Right now, job one is to get the first plant approved, financed and under construction and both Pentant as an advisor and I as a director have no greater priority.  The company is weeks away from the completion of audited financials, an important step for up-listing the stock to OTCQB, bringing us closer to breaking ground on the first plant.”

About BioNitrogen Holdings Corp.

BioNitrogen Holdings Corp. (OTC PINK: BION) is a cleantech company that utilizes patented technology to build environmentally friendly plants that convert biomass into urea fertilizer. Our mission is to provide safe, cost effective, green solutions that are economically beneficial in locations where biomass is produced and urea is consumed. Additional information can be found at

Safe Harbor Statement

Statements made in this press release that express the Company’s or management’s intentions, plans, beliefs, expectations or predictions of future events, are forward-looking statements. The words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “will” and similar expressions are intended to further identify such forward-looking statements, although not all forward-looking statements contain these identifying words. Those statements are based on many assumptions and are subject to many known and unknown risks, uncertainties and other factors that could cause the Company’s actual activities, results or performance to differ materially from those anticipated or projected in such forward-looking statements. The Company cannot guarantee future financial results; levels of activity, performance or achievements and investors should not place undue reliance on the Company’s forward-looking statements. No information contained in this press release should be construed as any indication whatsoever of the Company’s future financial performance, future revenues or its future stock price. The forward-looking statements contained herein represent the judgment of the Company as of the date of this press release, and the Company expressly disclaims any intent, obligation or undertaking to update or revise such forward-looking statements to reflect any change in the Company’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

To view the original version on PR Newswire, visit:

SOURCE BioNitrogen Holdings Corp.


2014 Investor Fact Sheet

Investor Alerts

Please provide us with your email address to receive investor alerts and other news.

Investor Relations Contact

Molly Nuland

Pentant LLC
(203) 553-9825

Select Language